Immunological outcomes in infants with ROP after dexamethasone and aminophylline

Area of Science:

• Anesthesiology
• Immunology
• Neonatology

Background:

• Preterm infants with severe retinopathy of prematurity (ROP) require anesthesia.
• The immunomodulatory effects of dexamethasone and aminophylline in this population are not fully understood.
• Cell-mediated immunity, specifically regulatory T-cells (T-reg), plays a crucial role in immune responses.

Purpose of the Study:

• To evaluate the impact of dexamethasone and aminophylline on cell-mediated immunity in preterm infants undergoing anesthesia for ROP.
• To analyze the effects of these immunomodulators on specific T-cell subsets (CD4+CD25+Foxp3+ T-reg and CD4+CD25highFoxp3+CD127low).
• To assess the clinical effects of these drugs on preterm infants during anesthesia.

Main Methods:

• A study involving 74 preterm infants (25-32 weeks gestation) with stages 3-5 ROP.
• Intravenous administration of dexamethasone and aminophylline 15 minutes before the end of sevoflurane anesthesia.
• Monitoring of clinical parameters and analysis of blood samples for T-cell subsets (T-reg) collected during anesthesia induction.

Main Results:

• Neither dexamethasone nor aminophylline demonstrated a significant effect on clinical parameters after a single dose.
• Dexamethasone induced a short-term negative shift in regulatory T-cell levels.
• Aminophylline improved pulmonary ventilation, reduced apnea frequency, and enhanced blood gas indices, with a prolonged positive effect over several days.

Conclusions:

• A single dose of dexamethasone negatively impacts regulatory T-cells in preterm infants, while aminophylline shows beneficial effects on respiratory function.
• Aminophylline may offer a more sustained positive clinical outcome with continued administration.
• Further research is needed to fully elucidate the long-term immunomodulatory effects and clinical benefits of these agents in neonates.